OCHSNER AMERICAN LEGION HOSPITAL
1. Target Overview & Investment Thesis
OCHSNER AMERICAN LEGION HOSPITAL is a 49-bed under-performing / distressed in JEFFRSON DAVIS PARISH, LA with $32.5M in net patient revenue and a -30.0% operating margin. The hospital serves a payer mix of 36.6% Medicare, 0.5% Medicaid, and 62.9% commercial.
Thesis: Turnaround. Our ML models identify $2.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -30.0% to -22.7% (+736bps).
| Net Revenue HCRIS | $32.5M |
| Current EBITDA COMPUTED | $-9.8M |
| Operating Margin COMPUTED | -30.0% |
| Occupancy HCRIS | 52.0% |
| Revenue / Bed COMPUTED | $663K |
| Net-to-Gross HCRIS | 34.0% |
| Distress Probability ML | 48.2% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -30.0% places it below the state median. Among 102 size-comparable peers (24-98 beds), the median margin is -5.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (24-98), prioritizing same-state peers. 102 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| OCHSNER AMERICAN LEGION HOSPIT (Target) | LA | 49 | $32.5M | -30.0% |
| UNIVERSITY HOSPITAL & CLINICS | LA | 52 | $158.9M | -33.4% |
| SOUTHERN REGIONAL MEDICAL CORP | LA | 64 | $97.3M | -50.0% |
| OCHSNER LSU HEALTH MONROE | LA | 84 | $85.1M | -50.0% |
| NATCHITOCHES REGIONAL MEDICAL | LA | 81 | $82.4M | -21.8% |
| LAKE AREA MEDICAL CENTER | LA | 88 | $81.6M | 2.2% |
| NEW ORLEANS EAST HOSPITAL | LA | 60 | $77.6M | -29.7% |
| OCHSNER BAYOU LLC | LA | 25 | $76.5M | -0.9% |
| OUR LADY OF THE ANGELS HOSPITA | LA | 36 | $76.2M | -4.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $682K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $649K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $643K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $395K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $21K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-9.8M |
| + RCM Uplift | +$2.4M |
| Pro Forma EBITDA | $-7.4M |
| Current Margin | -30.0% |
| Pro Forma Margin | -22.7% |
| WC Released (1x) | $1.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-15.0M | $-40.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-15.0M | $-49.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-13.5M | $-46.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-13.5M | $-54.5M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-16.5M | $-47.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-16.5M | $-57.6M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 102 hospitals with 24-98 beds
- Same-state prioritization (n=103)
- Comp margins: P25=-24.5% / P50=-5.0% / P75=4.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.